Literature DB >> 15491533

[Quality of life with chronic obstructive pulmonary disease: the influence of level of patient care].

J de Miguel Díez1, J L Izquierdo Alonso, J M Rodríguez González-Moro, P de Lucas Ramos, J M Bellón Cano, J Molina París.   

Abstract

OBJECTIVE: The aim of the study was to determine the factors related to the health-related quality of life (HRQL) of patients with stable chronic obstructive pulmonary disease (COPD) and to assess the degree of influence of level of patient care (primary or specialized). MATERIAL AND
METHOD: An observational descriptive, cross-sectional, multicenter study was carried out. The study sample was a randomized selection taken from a stratified sample of patients treated by primary care physicians and pneumologists from each Spanish region. Only those patients whose level of health care was indicated and whose diagnosis of COPD was confirmed by spirometry were enrolled in the study.
RESULTS: Five hundred sixty patients were assessed, 100 from primary health care and 460 from pneumology practices. No significant differences between the 2 levels of care were found in the scores on the HRQL questionnaire (Spanish version of the St George's Respiratory Questionnaire). There was a weak correlation between patients' perception of health and lung function parameters. Factors related to HRQL in the multivariate analysis were dyspnea, the presence of COPD exacerbations in the previous year, consequent visits to the emergency department, age, and degree of airflow restriction, but not level of patient care.
CONCLUSIONS: Stable COPD patients' HRQL is not related to their level of care, be it primary or specialized, but is related to other factors such as dyspnea, presence of exacerbations or consequent visits to the emergency department, age, and degree of airflow restriction.

Entities:  

Mesh:

Year:  2004        PMID: 15491533

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  7 in total

1.  Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Miriam Calle; Francisco Alvarez-Gutierrez; Elena Gobartt; Francisco López; Antonio Martín
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

2.  Health-related quality of life in patients with chronic obstructive pulmonary disease: A hospital-based study.

Authors:  Sidharth Kharbanda; R Anand
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 2.375

3.  Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study.

Authors:  Pilar Carrasco Garrido; Javier de Miguel Díez; Javier Rejas Gutiérrez; Antonio Martín Centeno; Elena Gobartt Vázquez; Angel Gil de Miguel; Marta García Carballo; Rodrigo Jiménez García
Journal:  Health Qual Life Outcomes       Date:  2006-05-23       Impact factor: 3.186

4.  Health-related quality of life of chronic obstructive pulmonary disease patients: Results from a community based cross-sectional study in Aligarh, Uttar Pradesh, India.

Authors:  Malik Shanawaz Ahmed; Arslan Neyaz; Ahmad Nadeem Aslami
Journal:  Lung India       Date:  2016 Mar-Apr

5.  Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.

Authors:  Cristina Represas-Represas; Alberto Fernández-Villar; Alberto Ruano-Raviña; Ana Priegue-Carrera; Maribel Botana-Rial
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

6.  Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.

Authors:  Javier de Miguel Diez; Pilar Carrasco Garrido; Marta García Carballo; Angel Gil de Miguel; Javier Rejas Gutierrez; José M Bellón Cano; Valentín Hernández Barrera; Rodrigo Jimenez García
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

7.  Validation of the portable Air-Smart Spirometer.

Authors:  Cristina Ramos Hernández; Marta Núñez Fernández; Abel Pallares Sanmartín; Cecilia Mouronte Roibas; Luz Cerdeira Domínguez; Maria Isabel Botana Rial; Nagore Blanco Cid; Alberto Fernández Villar
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.